771573-36-5 Usage
Description
3-Fluoro-2-methylbenzylamine, also known as o-fluoro-m-xyleneamine, is a colorless liquid chemical compound with the molecular formula C8H10FN. It has a faint odor and is commonly used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds.
Used in Pharmaceutical Industry:
3-Fluoro-2-methylbenzylamine is used as a building block for the production of pharmaceuticals, including antihistamines and antihypertensive agents, due to its ability to be incorporated into the molecular structures of these medications.
Used in Agrochemical Industry:
3-Fluoro-2-methylbenzylamine is used as an intermediate in the synthesis of agrochemicals, such as pesticides, where it contributes to the development of effective and targeted pest control solutions.
Used in Chemical Industry:
3-Fluoro-2-methylbenzylamine is used in the synthesis of other organic compounds, such as UV stabilizers, which are important for protecting materials from the damaging effects of ultraviolet radiation.
Safety and Handling:
This chemical should be stored and handled in a well-ventilated area, away from heat, sparks, and open flames. Appropriate personal protective equipment should be used when working with 3-fluoro-2-methylbenzylamine to ensure safety.
Check Digit Verification of cas no
The CAS Registry Mumber 771573-36-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,1,5,7 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 771573-36:
(8*7)+(7*7)+(6*1)+(5*5)+(4*7)+(3*3)+(2*3)+(1*6)=185
185 % 10 = 5
So 771573-36-5 is a valid CAS Registry Number.
771573-36-5Relevant articles and documents
TETRAHYDROISOQUINOLINE COMPOUND
-
Page/Page column 67-68, (2010/01/29)
The present invention relates a specific tetrahydroisoquinoline compound which is useful as a chemokine receptor type 3 (CCR3) antagonist, and a pharmaceutical composition comprising the same as an active ingredient. The tetrahydroisoquinoline compound of the present invention is useful for the treatment or prevention of a disease in which CCR3 participates.
